| Lastest Insider Transactions Of SUPERNUS PHARMACEUTICALS, INC. ( SUPN ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2026-08-12 | Option Exercise | 29,849 | 0.00 | 0 | 2026-08-14 17:12:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | 2026-08-12 | Option Exercise | 750 | 0.00 | 0 | 2026-08-14 17:11:50 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2026-08-12 | Option Exercise | 2,500 | 0.00 | 0 | 2026-08-14 17:11:16 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | 2026-08-12 | Option Exercise | 1,650 | 0.00 | 0 | 2026-08-14 17:10:26 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2026-08-12 | Option Exercise | 1,250 | 0.00 | 0 | 2026-08-14 17:09:36 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2026-03-16 | Sell | 107,250 | 50.24 | 5,388,432 | 2026-03-18 17:18:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2026-03-16 | Option Exercise | 107,250 | 36.29 | 3,892,393 | 2026-03-18 17:18:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2026-03-13 | Sell | 35,000 | 50.37 | 1,763,124 | 2026-03-16 16:08:19 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2026-03-12 | Sell | 5,369 | 50.61 | 271,725 | 2026-03-16 16:07:41 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2026-03-06 | Option Exercise | 38,640 | 0.00 | 0 | 2026-03-10 16:13:50 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | 2026-03-06 | Sell | 1,623 | 53.65 | 87,074 | 2026-03-10 16:13:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | 2026-03-06 | Option Exercise | 3,750 | 0.00 | 0 | 2026-03-10 16:13:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2026-03-06 | Option Exercise | 6,000 | 0.00 | 0 | 2026-03-10 16:12:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Horich William Todd | SVP, Commercial Operations | 2026-03-06 | Sell | 8,877 | 54.50 | 483,797 | 2026-03-10 16:12:10 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Horich William Todd | SVP, Commercial Operations | 2026-03-06 | Option Exercise | 7,500 | 0.00 | 0 | 2026-03-10 16:12:10 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2026-03-05 | Sell | 18,787 | 53.38 | 1,002,811 | 2026-03-09 16:06:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2026-03-05 | Option Exercise | 7,905 | 25.30 | 199,997 | 2026-03-09 16:06:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2026-02-23 | Option Exercise | 15,000 | 12.98 | 194,700 | 2026-02-25 16:36:03 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Directior | 2026-02-19 | Sell | 4,475 | 51.01 | 228,265 | 2026-02-23 16:39:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Directior | 2026-02-19 | Option Exercise | 4,475 | 0.00 | 0 | 2026-02-23 16:39:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2026-01-09 | Option Exercise | 15,000 | 12.98 | 194,700 | 2026-01-12 16:09:47 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | 2025-12-19 | Sell | 20,000 | 50.41 | 1,008,150 | 2025-12-22 16:04:25 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | 2025-12-19 | Option Exercise | 20,000 | 28.82 | 576,500 | 2025-12-22 16:04:25 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-12-18 | Sell | 710 | 44.44 | 31,552 | 2025-12-19 16:05:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-12-18 | Option Exercise | 1,500 | 0.00 | 0 | 2025-12-19 16:05:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-12-18 | Sell | 710 | 44.44 | 31,552 | 2025-12-19 16:05:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-12-18 | Option Exercise | 1,500 | 0.00 | 0 | 2025-12-19 16:05:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2025-11-21 | Option Exercise | 15,000 | 12.98 | 194,700 | 2025-11-24 18:16:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-10-09 | Sell | 59,900 | 50.57 | 3,029,337 | 2025-10-10 17:33:23 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-10-09 | Option Exercise | 81,250 | 25.30 | 2,055,625 | 2025-10-10 17:33:23 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2025-10-09 | Sell | 25,000 | 50.77 | 1,269,234 | 2025-10-10 16:21:00 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-10-02 | Sell | 1,904 | 48.06 | 91,506 | 2025-10-03 16:18:34 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-10-02 | Option Exercise | 2,267 | 25.30 | 57,355 | 2025-10-03 16:18:34 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-10-01 | Sell | 40,173 | 48.07 | 1,931,116 | 2025-10-02 16:02:42 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-10-01 | Option Exercise | 53,785 | 25.30 | 1,360,761 | 2025-10-02 16:02:42 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-30 | Sell | 8,588 | 48.25 | 414,371 | 2025-10-01 16:20:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-30 | Option Exercise | 11,510 | 25.30 | 291,203 | 2025-10-01 16:20:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-30 | Sell | 8,588 | 48.25 | 414,371 | 2025-10-01 16:20:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-30 | Option Exercise | 11,510 | 25.30 | 291,203 | 2025-10-01 16:20:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-29 | Sell | 10,235 | 48.02 | 491,485 | 2025-09-30 16:24:25 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-29 | Option Exercise | 13,688 | 25.30 | 346,306 | 2025-09-30 16:24:25 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | 2025-09-25 | Option Exercise | 1,875 | 0.00 | 0 | 2025-09-26 16:17:29 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-08 | Sell | 6,322 | 46.29 | 292,645 | 2025-09-09 16:21:18 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-08 | Option Exercise | 8,074 | 25.30 | 204,272 | 2025-09-09 16:21:18 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-05 | Sell | 55,578 | 46.01 | 2,557,144 | 2025-09-08 16:31:16 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-09-05 | Option Exercise | 73,176 | 25.30 | 1,851,353 | 2025-09-08 16:31:16 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-27 | Sell | 34,800 | 45.10 | 1,569,431 | 2025-08-29 16:05:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-27 | Option Exercise | 55,974 | 12.98 | 726,543 | 2025-08-29 16:05:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2025-08-27 | Sell | 3,588 | 45.01 | 161,496 | 2025-08-29 16:05:08 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-08-25 | Option Exercise | 1,250 | 0.00 | 0 | 2025-08-27 17:01:01 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2025-08-25 | Sell | 14,000 | 44.51 | 623,140 | 2025-08-27 16:59:36 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2025-08-25 | Option Exercise | 14,000 | 12.98 | 181,720 | 2025-08-27 16:59:36 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2025-08-25 | Sell | 1,000 | 45.00 | 45,000 | 2025-08-27 16:56:58 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-25 | Sell | 1,000 | 45.00 | 45,000 | 2025-08-27 16:56:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-25 | Option Exercise | 1,611 | 12.98 | 20,911 | 2025-08-27 16:56:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-25 | Sell | 1,000 | 45.00 | 45,000 | 2025-08-27 16:56:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-25 | Option Exercise | 1,611 | 12.98 | 20,911 | 2025-08-27 16:56:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2025-08-22 | Sell | 1,412 | 45.00 | 63,540 | 2025-08-26 16:19:57 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2025-08-22 | Sell | 11,780 | 44.49 | 524,092 | 2025-08-26 16:18:31 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-22 | Sell | 1,500 | 45.00 | 67,500 | 2025-08-26 16:08:54 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-22 | Option Exercise | 2,415 | 12.98 | 31,347 | 2025-08-26 16:08:54 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Directior | 2025-08-14 | Sell | 5,369 | 42.25 | 226,840 | 2025-08-18 16:31:18 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Directior | 2025-08-14 | Sell | 5,369 | 42.25 | 226,840 | 2025-08-18 16:31:18 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2025-08-14 | Sell | 7,457 | 42.26 | 315,133 | 2025-08-18 16:28:44 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2025-08-14 | Sell | 7,457 | 42.26 | 315,133 | 2025-08-18 16:28:44 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-06 | Sell | 140,000 | 42.02 | 5,883,360 | 2025-08-08 16:40:02 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-08-06 | Option Exercise | 201,250 | 17.95 | 3,613,225 | 2025-08-08 16:40:02 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-03-10 | Option Exercise | 35,000 | 0.00 | 0 | 2025-03-11 16:17:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2025-03-10 | Option Exercise | 3,800 | 0.00 | 0 | 2025-03-11 16:15:41 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2025-03-07 | Option Exercise | 38,640 | 0.00 | 0 | 2025-03-07 16:40:30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2025-03-07 | Option Exercise | 2,625 | 0.00 | 0 | 2025-03-07 16:34:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2025-02-26 | Option Exercise | 5,760 | 0.00 | 0 | 2025-02-26 17:56:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-02-21 | Option Exercise | 1,650 | 0.00 | 0 | 2025-02-24 20:22:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | 2025-02-21 | Sell | 927 | 39.15 | 36,292 | 2025-02-24 20:20:14 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | 2025-02-21 | Option Exercise | 1,875 | 0.00 | 0 | 2025-02-24 20:20:14 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2025-02-21 | Option Exercise | 1,125 | 0.00 | 0 | 2025-02-24 20:18:34 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-02-04 | Sell | 9,477 | 39.70 | 376,237 | 2025-02-05 16:37:12 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-02-04 | Option Exercise | 9,477 | 29.61 | 280,614 | 2025-02-05 16:37:12 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-01-27 | Sell | 3,273 | 39.62 | 129,676 | 2025-01-29 17:04:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2025-01-27 | Option Exercise | 3,273 | 29.61 | 96,914 | 2025-01-29 17:04:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2025-01-22 | Option Exercise | 20,000 | 9.13 | 182,600 | 2025-01-23 16:33:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | 2024-12-27 | Option Exercise | 2,625 | 0.00 | 0 | 2024-12-30 16:13:12 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2024-12-27 | Option Exercise | 52,640 | 0.00 | 0 | 2024-12-30 16:08:06 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-12-03 | Sell | 21,495 | 36.68 | 788,437 | 2024-12-04 16:36:28 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-12-03 | Option Exercise | 21,495 | 24.77 | 532,361 | 2024-12-04 16:36:28 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2024-11-11 | Sell | 10,700 | 36.24 | 387,768 | 2024-11-12 16:15:18 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2024-11-11 | Option Exercise | 20,000 | 9.13 | 182,600 | 2024-11-12 16:15:18 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2024-11-08 | Sell | 8,722 | 36.28 | 316,434 | 2024-11-12 16:14:14 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2024-11-08 | Sell | 10,787 | 36.30 | 391,568 | 2024-11-12 16:13:04 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2024-11-08 | Option Exercise | 10,787 | 11.46 | 123,619 | 2024-11-12 16:13:04 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2024-11-08 | Sell | 125,000 | 36.29 | 4,536,250 | 2024-11-12 16:11:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2024-11-08 | Option Exercise | 125,000 | 9.13 | 1,141,250 | 2024-11-12 16:11:32 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2024-11-07 | Sell | 15,000 | 36.98 | 554,700 | 2024-11-08 16:13:57 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2024-11-07 | Option Exercise | 15,000 | 9.13 | 136,950 | 2024-11-08 16:13:57 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2024-11-07 | Sell | 14,213 | 36.62 | 520,480 | 2024-11-08 16:11:58 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2024-11-07 | Option Exercise | 14,213 | 11.46 | 162,881 | 2024-11-08 16:11:58 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2024-11-07 | Sell | 125,000 | 36.68 | 4,585,000 | 2024-11-08 16:08:52 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2024-11-07 | Option Exercise | 125,000 | 9.13 | 1,141,250 | 2024-11-08 16:08:52 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2024-09-13 | Sell | 13,886 | 31.33 | 435,048 | 2024-09-17 16:10:48 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | GEMAYEL GEORGES | Directior | 2024-09-13 | Option Exercise | 10,000 | 11.46 | 114,600 | 2024-09-17 16:10:48 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-08-20 | Option Exercise | 1,250 | 0.00 | 0 | 2024-08-20 17:00:15 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-21 | Sell | 14,491 | 35.31 | 511,677 | 2024-03-25 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-21 | Option Exercise | 14,491 | 25.30 | 366,622 | 2024-03-25 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-20 | Sell | 400 | 35.31 | 14,124 | 2024-03-22 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-20 | Option Exercise | 400 | 25.30 | 10,120 | 2024-03-22 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-19 | Sell | 12,364 | 35.31 | 436,573 | 2024-03-21 17:01:05 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-19 | Option Exercise | 12,364 | 25.30 | 312,809 | 2024-03-21 17:01:05 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-13 | Sell | 62,366 | 33.74 | 2,104,289 | 2024-03-15 18:39:08 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-13 | Option Exercise | 62,366 | 17.61 | 1,098,523 | 2024-03-15 18:39:08 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-12 | Sell | 3,884 | 32.99 | 128,133 | 2024-03-14 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-12 | Option Exercise | 3,884 | 12.98 | 50,414 | 2024-03-14 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2024-02-28 | Option Exercise | 990 | 0.00 | 0 | 2024-02-29 17:01:46 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2024-02-28 | Option Exercise | 35,000 | 0.00 | 0 | 2024-02-29 17:00:51 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-02-26 | Sell | 5,000 | 30.21 | 151,050 | 2024-02-28 17:01:30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-02-26 | Option Exercise | 5,000 | 9.13 | 45,650 | 2024-02-28 17:01:30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2024-01-10 | Sell | 8,000 | 27.91 | 223,280 | 2024-01-12 17:00:24 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2024-01-10 | Option Exercise | 8,000 | 9.24 | 73,920 | 2024-01-12 17:00:24 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | Sr. VP, Chief Medical Officer | 2023-12-22 | Option Exercise | 600 | 0.00 | 0 | 2023-12-26 17:01:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-12-22 | Option Exercise | 25,000 | 0.00 | 0 | 2023-12-26 17:00:28 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2023-11-16 | Sell | 2,500 | 28.01 | 70,025 | 2023-11-20 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2023-11-16 | Option Exercise | 7,457 | 9.24 | 68,903 | 2023-11-20 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2023-11-15 | Sell | 9,093 | 28.50 | 259,151 | 2023-11-17 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2023-11-15 | Option Exercise | 7,457 | 9.24 | 68,903 | 2023-11-17 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2023-11-14 | Sell | 1,110 | 28.13 | 31,224 | 2023-11-16 17:00:06 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2023-11-14 | Option Exercise | 2,000 | 9.24 | 18,480 | 2023-11-16 17:00:06 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2023-10-13 | Option Exercise | 4,000 | 0.00 | 0 | 2023-10-13 17:00:09 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-09-07 | Option Exercise | 2,500 | 0.00 | 0 | 2023-09-07 17:00:26 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-09-07 | Option Exercise | 35,000 | 0.00 | 0 | 2023-09-07 17:00:14 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-08-30 | Sell | 8,100 | 32.00 | 259,200 | 2023-09-01 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-08-30 | Option Exercise | 8,100 | 23.99 | 194,319 | 2023-09-01 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-08-25 | Sell | 5,135 | 31.59 | 162,215 | 2023-08-29 17:00:48 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2023-05-11 | Option Exercise | 1,500 | 0.00 | 0 | 2023-05-12 17:00:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-05-11 | Option Exercise | 31,250 | 0.00 | 0 | 2023-05-12 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-05-11 | Option Exercise | 750 | 0.00 | 0 | 2023-05-12 17:00:20 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2023-03-14 | Option Exercise | 1,500 | 0.00 | 0 | 2023-04-10 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-03-14 | Option Exercise | 20,000 | 0.00 | 0 | 2023-04-10 17:00:30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | 2023-03-14 | Sell | 4,780 | 35.99 | 172,023 | 2023-03-16 17:00:55 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2023-02-16 | Option Exercise | 1,500 | 0.00 | 0 | 2023-02-21 17:35:38 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-02-16 | Option Exercise | 1,500 | 0.00 | 0 | 2023-02-21 17:01:54 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | 2023-02-16 | Option Exercise | 1,500 | 0.00 | 0 | 2023-02-21 17:01:38 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-02 | Sell | 13,732 | 42.05 | 577,492 | 2023-02-06 17:01:04 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-02 | Option Exercise | 22,845 | 9.56 | 218,398 | 2023-02-06 17:01:04 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-01 | Sell | 300 | 42.01 | 12,602 | 2023-02-03 17:00:49 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-01 | Option Exercise | 498 | 9.56 | 4,761 | 2023-02-03 17:00:49 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-31 | Sell | 976 | 42.01 | 41,002 | 2023-02-02 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-31 | Option Exercise | 1,620 | 9.56 | 15,487 | 2023-02-02 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-18 | Sell | 4,936 | 40.40 | 199,394 | 2023-01-20 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-18 | Option Exercise | 8,080 | 9.56 | 77,245 | 2023-01-20 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-17 | Sell | 4,826 | 39.92 | 192,638 | 2023-01-19 17:00:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-17 | Option Exercise | 4,826 | 9.13 | 44,061 | 2023-01-19 17:00:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-17 | Sell | 25,446 | 40.03 | 1,018,728 | 2023-01-19 17:00:46 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-17 | Option Exercise | 41,920 | 9.56 | 400,755 | 2023-01-19 17:00:46 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2022-03-14 | Option Exercise | 40,000 | 0.00 | 0 | 2023-01-13 17:00:58 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2023-01-10 | Option Exercise | 8,722 | 7.90 | 68,904 | 2023-01-12 17:00:38 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-06 | Sell | 174 | 39.90 | 6,943 | 2023-01-09 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-06 | Option Exercise | 174 | 9.13 | 1,589 | 2023-01-09 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2022-12-28 | Option Exercise | 8,722 | 7.90 | 68,904 | 2022-12-30 17:01:49 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2022-12-20 | Sell | 15,360 | 38.11 | 585,387 | 2022-12-22 17:00:56 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2022-12-20 | Option Exercise | 25,000 | 9.56 | 239,000 | 2022-12-22 17:00:56 |
